[HTML][HTML] Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
I Uri, S Grozinsky-Glasberg - Clinical diabetes and endocrinology, 2018 - Springer
Abstract Background Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated
annual incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
annual incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
I Uri, S Grozinsky-Glasberg - Clinical Diabetes and …, 2018 - search.proquest.com
The only treatment that offers a cure is surgery, however most patients are diagnosed with
metastatic disease, and curative surgery is usually not an option. Since the majority of …
metastatic disease, and curative surgery is usually not an option. Since the majority of …
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
I Uri, S Grozinsky-Glasberg - Clinical diabetes and …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
I Uri, S Grozinsky-Glasberg - Clinical Diabetes and Endocrinology, 2018 - go.gale.com
Background Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
[HTML][HTML] Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
I Uri, S Grozinsky-Glasberg - Clinical Diabetes and Endocrinology, 2018 - ncbi.nlm.nih.gov
Background Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
[HTML][HTML] Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
I Uri, S Grozinsky-Glasberg - Clinical …, 2018 - clindiabetesendo.biomedcentral …
Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual incidence of~
6.9/100,000. NETs arise throughout the body from cells of the diffuse endocrine system …
6.9/100,000. NETs arise throughout the body from cells of the diffuse endocrine system …
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
I Uri, S Grozinsky-Glasberg - Clinical Diabetes and Endocrinology, 2018 - europepmc.org
Background Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
I Uri, S Grozinsky-Glasberg - Clinical Diabetes and Endocrinology, 2018 - europepmc.org
Background Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
[PDF][PDF] Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
I Uri, S Grozinsky-Glasberg - 2018 - clindiabetesendo.biomedcentral …
Abstract Background: Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated
annual incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …
annual incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …